ELUTIA INC. — Director's Dealing 2022

Sep 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2022-09-08

Reporting Person: Englese Thomas (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-08	Class A Common Stock	M	15390	—	Acquired	21997	Direct
2022-09-08	Class A Common Stock	F	4728	$7.30	Disposed	17269	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-08	Restricted Stock Units	$	M	15390	Disposed		Class A Common Stock (15390)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

F2: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

F3: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.